Perrigo wins approval for renal failure drug

ALLEGAN, Mich. — The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.

Perrigo announced the approval of calcium acetate capsules, a generic version of Nabi Biopharmaceuticals' Phoslo Gelcaps. The drug is used to treat end-stage renal failure.

Perrigo settled a patent infringement lawsuit concerning the drug last year, though terms of the settlement were not disclosed. Annual sales of the branded version of the drug and generic versions were $95 million, according to Wolters Kluwer Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.